MedPath

The effect of administration time of oral iron preparations on hemoglobin response

Phase 3
Conditions
Iron deficiency anemia.
Iron deficiency anemia
Registration Number
IRCT20210503051166N2
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
196
Inclusion Criteria

Patients with iron deficiency anemia based on iron profile study such as serum iron, ferritin, and transferrin saturation percent
Hemoglobin level less than 11 mg/dl
Not suffering from chronic liver disease (normal bilirubin, LFT<2 times normal), or other chronic inflammatory diseases based on initial evaluation
Not suffering from active malignancy based on initial evaluation
Not suffering from active infection based on initial evaluation
Not suffering from any of the malabsorption syndromes based on the initial evaluation
Patients with cardiovascular risk factors

Exclusion Criteria

Suffering from any chronic kidney disease, liver disease, all types of cancer, infections and autoimmune diseases
The patient's lack of consent to participate in the plan
Having dyspepsia and intolerance to iron food products
High CRP levels at study entry

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Increase in hemoglobin level. Timepoint: before intervention and 4 weeks after intervention. Method of measurement: Hemoglobin concentration in complete blood count test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath